Author:
Mathis Benjamin,Haïne Max,Girard Raphaële,Bonnefoy Marc
Abstract
Abstract
Background
In the context of an aging population, identifying risk factors for Vancomycin-resistant enterococci (VRE), specific to older people, is important. However, if age is a known risk factor for VRE infection, a limited number of studies have focused on older patients. This study aimed to identify potential risk factors for VRE acquisition in a population aged 65 years and older, during a large VRE outbreak that occurred in a teaching hospital in Lyon, France, from December 2013 to July 2014.
Methods
The present retrospective, multi-center, descriptive, and analytical study used part of a previous cohort, and included only a sub-group of patients aged 65 years and older. The analysis of the factors included in the original study was completed with factors more specific to geriatric patients. Inclusion criteria were patients aged 65 years and older, in contact with a VRE index patient. Patients were screened by rectal swabs. Univariate and multivariate logistic regression analyses were performed.
Results
A total of 180 VRE contacts were included and 18 patients became carriers. Multivariate analysis showed that risk factors for VRE acquisition in older people included major contact type (RR: 5.31, 95%CI [1.33; 21.19]), number of antibiotics used (RR: 1.36, 95%CI [1.04; 1.76]), a score of McCabe = 2 (RR: 116.39, 95%CI [5.52; 2455.98]), ethylism (RR: 5.50, 95%CI [1.49; 20.25]), and dementia (RR: 7.50, 95%CI [1.89; 29.80]).
Conclusions
This study was able to demonstrate risk factors for VRE acquisition in older people. These risk factors should be taken into account when in the presence of older people in a VRE infected unit.
Publisher
Springer Science and Business Media LLC
Subject
Geriatrics and Gerontology
Reference28 articles.
1. Marion S, Caroline B, Anne-Gaëlle V, Mélanie C-C. Soing-Altrach, Sophan, Pontiès Valérie. Entérocoques résistants aux glycopeptides dans les établissements de santé en France : données épidémiologiques du signalement des infections nosocomiales, juillet 2001-juin 2015. Bull Epidémiol Hebd. 2016;24–25:419–27 http://invs.santepubliquefrance.fr/beh/2016/24-25/2016_24-25_3.html. .
2. Recommendations for Preventing the Spread of Vancomycin Resistance Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). https://www.cdc.gov/MMWR/preview/MMWRhtml/00039349.htm. Accessed 16 Nov 2019.
3. U. S Department of Health and Human Services - Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013. https://www.cdc.gov/drugresistance/threat-report-2013/. Accessed 7 Jun 2017.
4. HCSP. Prévention de la transmission croisée des Bactéries Hautement Résistantes aux antibiotiques émergentes (BHRe). 2013. https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=372. Accessed 10 Jun 2019.
5. Djembi LF, Hodille E, Chomat-Jaboulay S, Coudrais S, Santis ND, Gardes S, et al. Factors associated with Vancomycin-resistant Enterococcus acquisition during a large outbreak. J Infect Public Health 2016;0. doi:https://doi.org/10.1016/j.jiph.2016.04.010.